Healthy volunteers to test how common drugs alter new Medicine's effects
NCT ID NCT07590102
First seen May 16, 2026 · Last updated May 21, 2026 · Updated 1 time
Summary
This study looks at how a new drug, BGB-58067, is processed by the body when taken with two other common medicines. One medicine (phenytoin) speeds up the liver enzyme that breaks down BGB-58067, while the other (itraconazole) slows it down. The goal is to see how these interactions change drug levels in the blood. Thirty healthy adults will participate to help guide future dosing recommendations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.